(ShareCast News) - Shares in Premaitha Health are up more than 4% on news it has partnered with a major European diagnostics services group to implement the IONA test in at least two laboratories.The four-year Master Procurement Agreement (MPA) was to install the IONA test in at least two of the customer's laboratories.The customer intended to provide non-invasive prenatal testing (NIPT) services to its international network through these laboratories.There was potential to install the IONA test in additional laboratories in due course.The customer, said Premaitha, had a network of laboratories across Europe. It carried out more than 100m diagnostic tests annually.The MPA agreement set out the terms and pricing under which the IONA test could be offered across the customer's European hospital and laboratory network.At 12:26 GMT, shares in AIM-quoted Premaitha were up 4.05% to 9.62p each.